|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.80 EUR | -0.87% |
|
+2.66% | -14.40% |
| 02:24am | MERCK KGAA : Gets a Buy rating from JP Morgan | ZD |
| 12-03 | Merck KGaA Rebounds Sharply as Exane Drops Skepticism and Issues Positive Recommendation | DP |
| Capitalization | 52.46B 61.02B 49.14B 45.8B 84.6B 5,492B 92.02B 575B 222B 2,594B 229B 224B 9,484B | P/E ratio 2025 * |
18.3x | P/E ratio 2026 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise value | 60.48B 70.35B 56.65B 52.81B 97.53B 6,332B 106B 663B 256B 2,990B 264B 258B 10,934B | EV / Sales 2025 * |
2.86x | EV / Sales 2026 * | 2.73x |
| Free-Float |
29.72% | Yield 2025 * |
1.91% | Yield 2026 * | 2.02% |
Last Transcript: Merck KGaA
| 1 day | -0.87% | ||
| 1 week | +2.66% | ||
| Current month | +3.23% | ||
| 1 month | +9.16% | ||
| 3 months | +7.93% | ||
| 6 months | +3.32% | ||
| Current year | -14.40% |
| 1 week | 115.55 | 121.65 | |
| 1 month | 109.05 | 125.6 | |
| Current year | 100.7 | 154.65 | |
| 1 year | 100.7 | 154.65 | |
| 3 years | 100.7 | 202.8 | |
| 5 years | 100.7 | 231.5 | |
| 10 years | 70.68 | 231.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 2021-04-30 | |
| Director of Finance/CFO | 55 | 2023-06-30 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | 2019-04-25 |
Jürgen Glaser
BRD | Director/Board Member | 63 | 2012-04-30 |
| Director/Board Member | 76 | 2014-05-08 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.87% | +2.66% | -15.49% | -31.63% | 61.02B | ||
| -0.90% | -4.24% | +0.48% | -17.92% | 8.57B | ||
| +0.60% | -11.30% | +30.85% | +9.68% | 7.45B | ||
| -1.69% | -4.15% | +31.63% | +85.60% | 7.12B | ||
| -0.93% | -3.85% | +2.09% | +118.82% | 5.94B | ||
| +1.50% | +4.52% | +209.43% | +67.16% | 4.38B | ||
| +0.61% | -3.01% | -17.12% | -4.85% | 2.84B | ||
| +1.29% | +0.20% | +22.89% | +28.28% | 2.62B | ||
| -0.67% | +1.50% | +20.38% | +48.33% | 2.54B | ||
| +0.19% | +0.39% | -15.88% | +4.77% | 1.96B | ||
| Average | -0.09% | -1.49% | +26.93% | +30.82% | 10.44B | |
| Weighted average by Cap. | -0.61% | +1.08% | +4.56% | -1.99% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 21.13B 24.58B 19.8B 18.45B 34.08B 2,213B 37.07B 232B 89.41B 1,045B 92.27B 90.3B 3,821B | 21.39B 24.88B 20.03B 18.67B 34.49B 2,239B 37.52B 234B 90.48B 1,058B 93.38B 91.39B 3,867B |
| Net income | 2.84B 3.31B 2.66B 2.48B 4.58B 298B 4.99B 31.15B 12.03B 141B 12.41B 12.15B 514B | 2.87B 3.34B 2.69B 2.5B 4.62B 300B 5.03B 31.42B 12.13B 142B 12.52B 12.25B 518B |
| Net Debt | 8.02B 9.33B 7.51B 7B 12.94B 840B 14.07B 87.89B 33.94B 397B 35.02B 34.27B 1,450B | 6B 6.98B 5.62B 5.24B 9.68B 628B 10.53B 65.77B 25.39B 297B 26.21B 25.65B 1,085B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-08 | 119.75 € | -0.91% | 35,684 |
| 25-12-05 | 120.65 € | +1.05% | 255,519 |
| 25-12-04 | 119.40 € | -0.42% | 286,380 |
| 25-12-03 | 119.90 € | +2.70% | 345,142 |
| 25-12-02 | 116.75 € | +0.09% | 186,748 |
Delayed Quote Xetra, December 08, 2025 at 05:27 am
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MRK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















